Yusuke Shiozawa
Overview
Explore the profile of Yusuke Shiozawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
146
Citations
6869
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shiozawa Y, Parajuli K, Pienta K, Taichman R
Curr Osteoporos Rep
. 2024 Nov;
23(1):3.
PMID: 39585513
Purpose Of Review: Once prostate cancer (PCa) bone metastases develop, the prognosis dramatically declines. The precise mechanisms regulating bone metastasis remain elusive. This review will explore recent findings related to...
2.
Park S, Tsuzuki S, Contino K, Ollodart J, Eber M, Yu Y, et al.
Life Sci Alliance
. 2024 Sep;
7(12).
PMID: 39266299
Although the role of peripheral nerves in cancer progression has been appreciated, little is known regarding cancer/sensory nerve crosstalk and its contribution to bone metastasis and associated pain. In this...
3.
Iyoda S, Yoshida K, Shoji K, Ito N, Tanaka M, Nannya Y, et al.
Leukemia
. 2024 Apr;
38(7):1609-1612.
PMID: 38632314
No abstract available.
4.
Ollodart J, Steele L, Romero-Sandoval E, Strowd R, Shiozawa Y
Biochem Pharmacol
. 2024 Feb;
222:116070.
PMID: 38387528
Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating sequela that is difficult for both clinicians and cancer patients to manage. Precise mechanisms of CIPN remain elusive and current clinically prescribed therapies...
5.
Contino K, Cook K, Shiozawa Y
J Bone Oncol
. 2024 Jan;
44:100523.
PMID: 38274305
The importance of the gut microbiota in human health has become increasingly apparent in recent years, especially when the relationship between microbiota and host is no longer symbiotic. It has...
6.
Jimenez-Andrade J, Ramirez-Rosas M, Park S, Parker R, Eber M, Cain R, et al.
J Bone Oncol
. 2023 Dec;
43:100510.
PMID: 38075938
Cancer-induced bone pain (CIBP) is the most common and devastating symptom of bone metastatic cancer that substantially disrupts patients' quality of life. Currently, there are few effective analgesic treatments for...
7.
Nishimura T, Kakiuchi N, Yoshida K, Sakurai T, Kataoka T, Kondoh E, et al.
Nature
. 2023 Jul;
620(7974):607-614.
PMID: 37495687
Recent studies have documented frequent evolution of clones carrying common cancer mutations in apparently normal tissues, which are implicated in cancer development. However, our knowledge is still missing with regard...
8.
Hara Y, Shiba N, Yoshida K, Yamato G, Kaburagi T, Shiraishi Y, et al.
Genes Chromosomes Cancer
. 2023 Apr;
62(7):412-422.
PMID: 37102302
Pediatric acute myeloid leukemia (AML) is a poor prognostic subtype of pediatric leukemia. However, the detailed characteristics of many genetic abnormalities are yet to be established in this disease. Although...
9.
Sorimachi Y, Kobayashi H, Shiozawa Y, Koide S, Nakato R, Shimizu Y, et al.
Stem Cell Reports
. 2023 Apr;
18(5):1211-1226.
PMID: 37059101
Soft tissue sarcomas (STSs) are a heterogeneous group of tumors that originate from mesenchymal cells. p53 is frequently mutated in human STS. In this study, we found that the loss...
10.
Nannya Y, Tobiasson M, Sato S, Bernard E, Ohtake S, Takeda J, et al.
Blood Adv
. 2023 Mar;
7(14):3624-3636.
PMID: 36989067
Azacitidine is a mainstay of therapy for myelodysplastic syndrome (MDS)-related diseases. The purpose of our study is to elucidate the effect of gene mutations on hematological response and overall survival...